Clinical laboratory detection of carbapenem-resistant and carbapenemase-producing Enterobacteriaceae

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Expert Review of Anti-Infective Therapy

• Publication date

  2016-07-11

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1080/14787210.2016.1206815PMID 27348447
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Analytical Performance of Multiplexed Screening Test for 10 Antibiotic Resistance Genes from Perianal Swab Samples.

  2016cited by this paper
• Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011–2014

  2016cited by this paper
• Detection of carbapenemase activity in Enterobacteriaceae: comparison of the carbapenem inactivation method versus the Carba NP test.

  2016influential reference
• Emerging Resistance, New Antimicrobial Agents  …  but No Tests! The Challenge of Antimicrobial Susceptibility Testing in the Current US Regulatory Landscape.

  2016cited by this paper
• Evaluation of the FilmArray Blood Culture Identification Panel: Results of a Multicenter Controlled Trial

  2016cited by this paper
• Improved Phenotype-Based Definition for Identifying Carbapenemase Producers among Carbapenem-Resistant Enterobacteriaceae

  2015cited by this paper
• The Carbapenem Inactivation Method (CIM), a Simple and Low-Cost Alternative for the Carba NP Test to Assess Phenotypic Carbapenemase Activity in Gram-Negative Rods

  2015cited by this paper
• An 11,000-isolate same plate/same day comparison of the 3 most widely used platforms for analyzing multidrug-resistant clinical pathogens.

  2015cited by this paper
• Superbugs on Duodenoscopes: the Challenge of Cleaning and Disinfection of Reusable Devices

  2015cited by this paper
• Commentary: Continuing Challenges for the Clinical Laboratory for Detection of Carbapenem-Resistant Enterobacteriaceae

  2015cited by this paper
• Infections Caused by Resistant Gram‐Negative Bacteria: Epidemiology and Management

  2015cited by this paper
• Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015.

  2015cited by this paper
• Evaluation of the RAPIDEC® CARBA NP, the Rapid CARB Screen® and the Carba NP test for biochemical detection of carbapenemase-producing Enterobacteriaceae.

  2015cited by this paper
• Identification of Gram-Negative Bacteria and Genetic Resistance Determinants from Positive Blood Culture Broths by Use of the Verigene Gram-Negative Blood Culture Multiplex Microarray-Based Molecular Assay

  2015cited by this paper
• Evaluation of the Rapidec Carba NP Test for Detection of Carbapenemases in Enterobacteriaceae

  2015cited by this paper
• Epidemiology of the beta-lactamase resistome among Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae in the Chicago region

  2015cited by this paper
• Evaluation of three commercial assays for rapid detection of genes encoding clinically relevant carbapenemases in cultured bacteria.

  2015influential reference
• Detection of Carbapenemases in Clinical Enterobacteriaceae Isolates Using the VITEK AST-N202 Card

  2015cited by this paper
• Evaluation of Two Phenotypic Screening Tests for Carbapenemase-Producing Enterobacteriaceae

  2015cited by this paper
• Triton Hodge Test: Improved Protocol for Modified Hodge Test for Enhanced Detection of NDM and Other Carbapenemase Producers

  2015cited by this paper
• Antibiotic resistance threats in the United States: stepping back from the brink.

  2014cited by this paper
• Evaluation of the Carba NP Test for Carbapenemase Detection

  2014cited by this paper
• Rising Rates of Carbapenem-Resistant Enterobacteriaceae in Community Hospitals: A Mixed-Methods Review of Epidemiology and Microbiology Practices in a Network of Community Hospitals in the Southeastern United States

  2014cited by this paper
• Comparison of the Carba NP test with the Rapid CARB Screen Kit for the detection of carbapenemase-producing Enterobacteriaceae and Pseudomonas aeruginosa

  2014cited by this paper
• KPC-2 and OXA-48 carbapenemase-harbouring Enterobacteriaceae detected in an Austrian wastewater treatment plant.

  2014cited by this paper
• Carbapenem‐resistant Enterobacteriaceae: biology, epidemiology, and management

  2014cited by this paper
• Performance of Vitek 2 for Antimicrobial Susceptibility Testing of Enterobacteriaceae with Vitek 2 (2009 FDA) and 2014 CLSI Breakpoints

  2014cited by this paper
• Carbapenem-Resistant Klebsiella pneumoniae Producing New Delhi Metallo-β-Lactamase at an Acute Care Hospital, Colorado, 2012

  2014cited by this paper
• Evaluation of Check-Points Check-MDR CT103 PCR-Microarray Kit for Detection and Classification of ESBL, AmpC and Carbapenemase Genes

  2014influential reference
• Phenotypic and Molecular Characteristics of Carbapenem-Resistant Enterobacteriaceae in a Health Care System in Los Angeles, California, from 2011 to 2013

  2014cited by this paper
• Evaluation of the NucliSENS EasyQ KPC Assay for Detection of Klebsiella pneumoniae Carbapenemase-Producing Enterobacteriaceae

  2013cited by this paper
• Modified Hodge Test versus Indirect Carbapenemase Test: Prospective Evaluation of a Phenotypic Assay for Detection of Klebsiella pneumoniae Carbapenemase (KPC) in Enterobacteriaceae

  2013cited by this paper
• Antimicrobial-Resistant Pathogens Associated with Healthcare-Associated Infections Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010

  2013cited by this paper
• New Delhi Metallo-β-Lactamase–producing Enterobacteriaceae, United States

  2013cited by this paper
• EUCAST expert rules in antimicrobial susceptibility testing.

  2013influential reference
• Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases.

  2013cited by this paper
• Rapid detection of carbapenemase genes by multiplex real-time PCR.

  2012cited by this paper
• INVITED A RTICLE MEDICAL M ICROBIOLOGY

  2012cited by this paper
• Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy.

  2012cited by this paper
• Are susceptibility tests enough, or should laboratories still seek ESBLs and carbapenemases directly?

  2012cited by this paper
• OXA-48-like carbapenemases: the phantom menace.

  2012cited by this paper
• Laboratory Detection of Enterobacteriaceae That Produce Carbapenemases

  2012cited by this paper
• Spectrophotometry-based detection of carbapenemase producers among Enterobacteriaceae.

  2012cited by this paper
• Rapid Detection of Carbapenemase-producing Enterobacteriaceae

  2012cited by this paper
• EUCAST guidelines for detection of resistance mechanisms and specific resistances of clinical and/or epidemiological importance

  2012cited by this paper
• Carbapenem resistance in Klebsiella pneumoniae due to the New Delhi Metallo-β-lactamase.

  2011cited by this paper
• Molecular Dissection of an Outbreak of Carbapenem-Resistant Enterobacteriaceae Reveals Intergenus KPC Carbapenemase Transmission through a Promiscuous Plasmid

  2011cited by this paper
• Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study.

  2011cited by this paper
• Comparison of disk diffusion, Etest and VITEK2 for detection of carbapenemase-producing Klebsiella pneumoniae with the EUCAST and CLSI breakpoint systems.

  2011cited by this paper
• Multiplex PCR for detection of acquired carbapenemase genes.

  2011cited by this paper
• Detection of Klebsiella pneumoniae Carbapenemase (KPC) Production in Non-Klebsiella pneumoniae Enterobacteriaceae Isolates by Use of the Phoenix, Vitek 2, and Disk Diffusion Methods

  2011cited by this paper
• Value of the Modified Hodge Test for Detection of Emerging Carbapenemases in Enterobacteriaceae

  2011cited by this paper
• Cefazolin and enterobacteriaceae: rationale for revised susceptibility testing breakpoints.

  2011cited by this paper
• KPC Screening by Updated BD Phoenix and Vitek 2 Automated Systems

  2011cited by this paper
• Comparison of Polymyxin B, Tigecycline, Cefepime, and Meropenem MICs for KPC-Producing Klebsiella pneumoniae by Broth Microdilution, Vitek 2, and Etest

  2011cited by this paper
• Review of carbapenemases and AmpC-beta lactamases.

  2011cited by this paper
• Comparison of BD Phoenix, Vitek 2, and MicroScan Automated Systems for Detection and Inference of Mechanisms Responsible for Carbapenem Resistance in Enterobacteriaceae

  2010cited by this paper
• Can We Use Imipenem and Meropenem Vitek 2 MICs for Detection of Suspected KPC and Other-Carbapenemase Producers among Species of Enterobacteriaceae?

  2010cited by this paper
• Performance Standards for Antimicrobial Susceptibility Testing: Twenty-First Informational Supplement

  2010cited by this paper
• Extended-Spectrum-β-Lactamase, AmpC, and Carbapenemase Issues

  2010cited by this paper
• Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts.

  2010cited by this paper
• Comparison of Meropenem MICs and Susceptibilities for Carbapenemase-Producing Klebsiella pneumoniae Isolates by Various Testing Methods

  2010influential reference
• Cloverleaf test (modified Hodge test) for detecting carbapenemase production in Klebsiella pneumoniae: be aware of false positive results.

  2010cited by this paper
• Genetic Factors Associated with Elevated Carbapenem Resistance in KPC-Producing Klebsiella pneumoniae

  2010cited by this paper
• Controlling False-Positive Results Obtained with the Hodge and Masuda Assays for Detection of Class A Carbapenemase in Species of Enterobacteriaceae by Incorporating Boronic Acid

  2010cited by this paper
• Prospective Observational Study of the Impact of VIM-1 Metallo-β-Lactamase on the Outcome of Patients with Klebsiella pneumoniae Bloodstream Infections

  2009cited by this paper
• Molecular Epidemiology of KPC-Producing Klebsiella pneumoniae Isolates in the United States: Clonal Expansion of Multilocus Sequence Type 258

  2009cited by this paper
• Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program: a 10-year experience in the United States (1999-2008).

  2009cited by this paper
• First Isolation of the blaOXA-23 Carbapenemase Gene from an Environmental Acinetobacter baumannii Isolate

  2009cited by this paper
• Overexpression of the Naturally Occurring blaOXA-51 Gene in Acinetobacter baumannii Mediated by Novel Insertion Sequence ISAba9

  2009cited by this paper
• Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007

  2008cited by this paper
• Breakpoints for intravenously used cephalosporins in Enterobacteriaceae--EUCAST and CLSI breakpoints.

  2008cited by this paper
• Carbapenemases: the Versatile β-Lactamases

  2007cited by this paper
• Carbapenemases: the versatile beta-lactamases.

  2007cited by this paper
• Novel Carbapenem-Hydrolyzing β-Lactamase, KPC-1, from a Carbapenem-Resistant Strain of Klebsiella pneumoniae

  2001cited by this paper
• Performance standards for antimicrobial susceptibility testing

  2001cited by this paper
• Worldwide emergence of carbapenem-resistant Acinetobacter spp.

  1998cited by this paper
• A functional classification scheme for beta-lactamases and its correlation with molecular structure

  1995cited by this paper
• Characterization of beta-lactamases

  1989cited by this paper

• Comparative analysis of selected methods of carbapenemase determination among clinical Klebsiella pneumoniae

  2025cites this paper
• Investigation of genotyping and phenotyping characteristics of carbapenem-resistant Klebsiella pneumoniae isolates.

  2024cites this paper
• A Method for Detecting Five Carbapenemases in Bacteria Based on CRISPR-Cas12a Multiple RPA Rapid Detection Technology

  2024cites this paper
• PCR-dipstick DNA Chromatography for detection of Carbapenemase Producing Carbapenem-Resistant Enterobacteriaceae

  2023cites this paper
• In vitro activity of cefiderocol and other newly approved antimicrobials against multi-drug resistant Gram-negative pathogens recovered in intensive care units in Spain and Portugal

  2023cites this paper
• Fecal Carriage of Extended-Spectrum β-Lactamase-/AmpC-Producing Escherichia coli in Pet and Stray Cats

  2023influential citation
• Cefepime in vivo activity against carbapenem-resistant Enterobacterales that test as cefepime susceptible or susceptible-dose dependent in vitro: implications for clinical microbiology laboratory and clinicians.

  2023cites this paper
• Disinfection Strategies for Carbapenem-Resistant Klebsiella pneumoniae in a Healthcare Facility

  2022cites this paper
• Determination of Carbapenemase Production by BD Phoenix CPO Method in Karbapenem Resistant Klebsiella pneumoniae and Escherichia coli Isolates

  2022cites this paper
• Prevalence of Enterobacteriaceae producing carbapenemase (OXA-48) responsible for urinary tract infections in Casablanca

  2022cites this paper
• Liquid Chromatography-Tandem Mass Spectrometry Analysis Demonstrates a Decrease in Porins and Increase in CMY-2 β-Lactamases in Escherichia coli Exposed to Increasing Concentrations of Meropenem

  2022influential citation
• Multiplex Real-Time PCR Assay for Six Major Carbapenemase Genes

  2021cites this paper
• Characterisation of carbapenem-resistant Gram-negative organisms from clinical specimens in Yola, Nigeria

  2020cites this paper
• A simple phenotypic test for detecting the contribution of outer membrane permeability to carbapenem resistance.

  2020cites this paper
• Precision medicine for the diagnosis and treatment of carbapenem-resistant Enterobacterales: time to think from a different perspective

  2020cites this paper
• 'CRE, CRO, CPE and CPO': terminology past its 'sell-by-date' in an era of new antibiotics and regional carbapenemase epidemiology.

  2020cites this paper
• Multicenter Evaluation of Xpert Carba-R Assay for detection and identification of the carbapenemase genes in rectal swabs and clinical isolates.

  2020cites this paper
• Screening of Klebsiella Pneumoniae for Carbapenem Resistance and MIC of Imipenem

  2020cites this paper
• Hypervirulence and carbapenem resistance: two distinct evolutionary directions that led high-risk Klebsiella pneumoniae clones to epidemic success

  2019cites this paper
• Carbapenem-Resistant Klebsiella pneumoniae: Microbiology Key Points for Clinical Practice

  2019cites this paper
• 24th International Symposium on Infections in the Critically Ill Patient

  2019cites this paper
• Rapid antimicrobial susceptibility tests for sepsis; the road ahead.

  2019cites this paper
• Diagnosis and Treatment of Carbapenemase-Producing Organisms—an Update

  2019cites this paper
• Rapid detection of carbapenemase-producing Acinetobacter baumannii and carbapenem-resistant Enterobacteriaceae using a bioluminescence-based phenotypic method.

  2018cites this paper
• Prevalence of Mycoplasma genitalium and Azithromycin-resistant Infections Among Remnant Clinical Specimens, Los Angeles

  2018cites this paper
• New Bugs and New Drugs: Updates in Clinical Microbiology.

  2018cites this paper
• Direct-from-Blood-Culture Disk Diffusion To Determine Antimicrobial Susceptibility of Gram-Negative Bacteria: Preliminary Report from the Clinical and Laboratory Standards Institute Methods Development and Standardization Working Group

  2018cites this paper
• Evaluation of the commercial combined disk test and minimum inhibitory concentration (MIC) determination for detection of carbapenemase producers among Gram-negative bacilli isolated in a region with high prevalence of blaOXA-48 and blaNDM

  2018cites this paper
• Molecular Detection and Characterization of Carbapenem-Resistant Enterobacteriaceae

  2018cites this paper
• Control of Carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa in Healthcare Facilities: A Systematic Review and Reanalysis of Quasi-experimental Studies

  2018cites this paper
• Comparative evaluation of in‐house Carba NP test with other phenotypic tests for rapid detection of carbapenem‐resistant Enterobacteriaceae

  2018cites this paper
• Multidrug-Resistant Gram-Negative Bacilli: Infection Prevention Considerations

  2018cites this paper
• Defining the Aetiology and Antimicrobial Susceptibility Patterns of the Predominant Bacteria Associated with Bloodstream Infections at the Hospital for Tropical Diseases in Ho Chi Minh City, Vietnam

  2018cites this paper
• Carbapenem-Resistant Enterobacteriaceae Detection Practices in California: What Are We Missing?

  2018cites this paper
• Wild-Type Gyrase A Genotype of Neisseria gonorrhoeae Predicts In Vitro Susceptibility to Ciprofloxacin: A Systematic Review of the Literature and Meta-Analysis

  2017cites this paper
• Use of Ancillary Carbapenemase Tests To Improve Specificity of Phenotypic Definitions for Carbapenemase-Producing Enterobacteriaceae

  2017influential citation
• Molecular epidemiology of Escherichia coli sequence type 131 and its H30/H30-Rx subclones recovered from extra-intestinal infections: first report of OXA-48 producing ST131 clone from Iran

  2017cites this paper
• Is This the Carbapenemase Test We've Been Waiting for? A Multicenter Evaluation of the Modified Carbapenem Inactivation Method

  2017cites this paper